Comenzo RL - Search Results

1

Seeking confidence in the diagnosis of systemic AL (Ig light-chain) amyloidosis: patients can have both monoclonal gammopathies and hereditary amyloid proteins.

Comenzo RL, Zhou P, Fleisher M, Clark B, Teruya-Feldstein J. Comenzo RL, et al. Blood. 2006 May 1;107(9):3489-91. doi: 10.1182/blood-2005-10-4148. Epub 2006 Jan 26. Blood. 2006. PMID: 16439680 Free article.

2

Clonal immunoglobulin light chain variable region germline gene use in AL amyloidosis: association with dominant amyloid-related organ involvement and survival after stem cell transplantation.

Comenzo RL, Wally J, Kica G, Murray J, Ericsson T, Skinner M, Zhang Y. Comenzo RL, et al. Br J Haematol. 1999 Sep;106(3):744-51. doi: 10.1046/j.1365-2141.1999.01591.x. Br J Haematol. 1999. PMID: 10468868 Free article.

3

The tropism of organ involvement in primary systemic amyloidosis: contributions of Ig V(L) germ line gene use and clonal plasma cell burden.

Comenzo RL, Zhang Y, Martinez C, Osman K, Herrera GA. Comenzo RL, et al. Blood. 2001 Aug 1;98(3):714-20. doi: 10.1182/blood.v98.3.714. Blood. 2001. PMID: 11468171 Free article.

4

Autologous stem cell transplantation for primary systemic amyloidosis.

Comenzo RL, Gertz MA. Comenzo RL, et al. Blood. 2002 Jun 15;99(12):4276-82. doi: 10.1182/blood.v99.12.4276. Blood. 2002. PMID: 12036853 Free article. Review.

5

Primary systemic amyloidosis.

Comenzo RL. Comenzo RL. Curr Treat Options Oncol. 2000 Apr;1(1):83-9. doi: 10.1007/s11864-000-0018-9. Curr Treat Options Oncol. 2000. PMID: 12057064 Review.

6

Melphalan-mobilized blood stem cell components contain minimal clonotypic myeloma cell contamination.

Zhou P, Zhang Y, Martinez C, Kalakonda N, Nimer SD, Comenzo RL. Zhou P, et al. Among authors: comenzo rl. Blood. 2003 Jul 15;102(2):477-9. doi: 10.1182/blood-2002-12-3674. Epub 2003 Mar 20. Blood. 2003. PMID: 12649134 Free article. Clinical Trial.

7

Expression of cancer/testis (CT) antigens MAGE-A1, MAGE-A3, MAGE-A4, CT-7, and NY-ESO-1 in malignant gammopathies is heterogeneous and correlates with site, stage and risk status of disease.

Dhodapkar MV, Osman K, Teruya-Feldstein J, Filippa D, Hedvat CV, Iversen K, Kolb D, Geller MD, Hassoun H, Kewalramani T, Comenzo RL, Coplan K, Chen YT, Jungbluth AA. Dhodapkar MV, et al. Among authors: comenzo rl. Cancer Immun. 2003 Jul 23;3:9. Cancer Immun. 2003. PMID: 12875607

8

Insights into extramedullary tumour cell growth revealed by expression profiling of human plasmacytomas and multiple myeloma.

Hedvat CV, Comenzo RL, Teruya-Feldstein J, Olshen AB, Ely SA, Osman K, Zhang Y, Kalakonda N, Nimer SD. Hedvat CV, et al. Among authors: comenzo rl. Br J Haematol. 2003 Sep;122(5):728-44. doi: 10.1046/j.1365-2141.2003.04481.x. Br J Haematol. 2003. PMID: 12930383 Free article.

9

Maintaining the self-renewal and differentiation potential of human CD34+ hematopoietic cells using a single genetic element.

Mulloy JC, Cammenga J, Berguido FJ, Wu K, Zhou P, Comenzo RL, Jhanwar S, Moore MA, Nimer SD. Mulloy JC, et al. Among authors: comenzo rl. Blood. 2003 Dec 15;102(13):4369-76. doi: 10.1182/blood-2003-05-1762. Epub 2003 Aug 28. Blood. 2003. PMID: 12946995 Free article.

10

Systemic AL amyloidosis due to non-Hodgkin's lymphoma: an unusual clinicopathologic association.

Cohen AD, Zhou P, Xiao Q, Fleisher M, Kalakonda N, Akhurst T, Chitale DA, Moscowitz C, Dhodapkar MV, Teruya-Feldstein J, Filippa D, Comenzo RL. Cohen AD, et al. Among authors: comenzo rl. Br J Haematol. 2004 Feb;124(3):309-14. doi: 10.1046/j.1365-2141.2003.04779.x. Br J Haematol. 2004. PMID: 14717777 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

194 results

Search Page

Filters